Bloomberg News

The New Viagra: Good Old Testosterone

May 02, 2012

Bloomberg's Josh Lipton reports that Eli Lilly & Co. and Abbott Laboratories are offering help to the 13.8 million American men who have low levels of testosterone. Doctors warn demand for the treatments could lead to overuse with deadly side effects. In what may become one of the most sought after sex enhancement treatments since the introduction of Viagra 14 years ago. He speaks on Bloomberg Television's "Inside Track." (Source: Bloomberg)

Running Time: 03:20


Tim Cook's Reboot
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus